Summary

• Page properties (1 modified, 0 added, 0 removed)

Details

Page properties

Content

...	...	@@ -14,6 +14,10 @@
14	14
15	15	Biocon is steadfastly investing in developing novel therapies for diabetes, oncology and immunology. Biocon is strengthening its global reach and economies of scale.
16	16
	17	+
	18	+[[image:BIOCON.jpg]]
	19	+
	20	+
17	17	== Key Therapeutic Areas ==
18	18
19	19	At Biocon, its focus is on the three key therapeutic areas – Diabetes, Oncology & Immunology. Through its unique R&D story, which is built on world-class competence and capability, robust infrastructure, and a talent pool with extensive global development experience, the company aim to improve lives by making affordable life-saving solutions more accessible globally.{{footnote}}https://www.biocon.com/products/key-therapeutic-areas/{{/footnote}}
...	...	@@ -22,8 +22,6 @@
22	22	* Oncology
23	23	* Immunology
24	24
25		-{{putFootnotes/}}
26		-
27	27	= Business Review =
28	28
29	29	== Small Molecules API and Generic Formulations ==